Models
PRISM MEDICO AND PHARMACY LTD.BSE 512217Finance
-15per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model(15)implied P/B (1.54)× on FY19 book
Against CMP ₹29.84149.4%close of 2026-09-10
Cost of equity7.35%risk-free + beta × equity risk premium
Book equity, FY1910per share · excess returns add ₹(24)
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Excess-return schedule · ₹ crore · book equity earns your ROE; value is book plus the returns above the cost of equity

₹ croreFY20FY21FY22FY23FY24
Opening book equity1313131313
Net income at 0.3% ROE00000
Cost of equity charge at 7.35%(1)(1)(1)(1)(1)
Excess return(1)(1)(1)(1)(1)
Present value(1)(1)(1)(1)(1)
Closing book equity1313131313
Book equity today13
PV of 5 years of excess return(4)
PV of the terminal excess return, 5% flat(29)
add non-operating investments0
Equity value(20)
÷ 1.36 crore shares(15)
ROE is at or below the cost of equity, so every year destroys value against book and the model lands below book value. That is the arithmetic, not a view.

Where the methods land · ₹ per share · the dashed line is the CMP

52-week rangetraded range, a fact not a value
1634

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingExcess returnROE 0.3%7.35%5%(15)(149.4)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.